AstraZeneca acquires specialty pharma company Omthera for $323 million

09:29 AM | May 28, 2013 | Natasha Alperowicz

AstraZeneca today announced that it has agreed to acquire Omthera Pharmaceuticals (Princeton, NJ), a specialty pharmaceutical company focused on the development and commercialization of new therapies...